Establishment Labs (NASDAQ:ESTA) Trading 7.9% Higher - Here's Why

Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report)'s share price shot up 7.9% during trading on Tuesday . The company traded as high as $45.72 and last traded at $46.28. 601,434 shares were traded during mid-day trading, an increase of 46% from the average session volume of 411,352 shares. The stock had previously closed at $42.88.

Analysts Set New Price Targets

Separately, Stephens reaffirmed an "overweight" rating and issued a $52.00 price objective on shares of Establishment Labs in a research note on Thursday. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $57.40.

Establishment Labs Stock Performance

The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The company has a 50 day simple moving average of $37.37 and a 200-day simple moving average of $41.37. The stock has a market capitalization of $1.20 billion, a price-to-earnings ratio of -16.16 and a beta of 0.95.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The business had revenue of $44.51 million during the quarter, compared to analyst estimates of $44.45 million. As a group, equities research analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Remove Ads

Institutional Investors Weigh In On Establishment Labs

Several hedge funds and other institutional investors have recently modified their holdings of the company. Brown Advisory Inc. increased its holdings in shares of Establishment Labs by 23.1% during the fourth quarter. Brown Advisory Inc. now owns 2,338,369 shares of the company's stock valued at $107,729,000 after acquiring an additional 438,057 shares in the last quarter. Capital Research Global Investors increased its holdings in shares of Establishment Labs by 29.3% during the fourth quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock valued at $88,064,000 after acquiring an additional 433,484 shares in the last quarter. Findell Capital Management LLC increased its holdings in shares of Establishment Labs by 28.5% during the fourth quarter. Findell Capital Management LLC now owns 1,346,480 shares of the company's stock valued at $62,032,000 after acquiring an additional 298,380 shares in the last quarter. William Blair Investment Management LLC increased its holdings in shares of Establishment Labs by 44.1% during the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock valued at $37,447,000 after acquiring an additional 248,888 shares in the last quarter. Finally, Bamco Inc. NY increased its holdings in shares of Establishment Labs by 53.8% during the fourth quarter. Bamco Inc. NY now owns 752,886 shares of the company's stock valued at $34,685,000 after acquiring an additional 263,500 shares in the last quarter. Institutional investors own 72.91% of the company's stock.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.